3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
9
Sarcoma
5
NET
3
Endocrine
3
Genitourinary
2
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
227
Lymphoma
225
Lymphoma, Non-Hodgkin
197
Leukemia, Lymphocytic, Chronic, B-Cell
176
Lymphoma, Large B-Cell, Diffuse
171
Lymphoma, Follicular
167
Lymphoma, B-Cell
109
Lymphoma, Mantle-Cell
103
Hodgkin Disease
99
Leukemia, Myeloid, Acute
96
Recurrence
94
Multiple Myeloma
89
Burkitt Lymphoma
86
Leukemia
76
Neoplasms
66
Hematologic Neoplasms
58
Lymphoma, B-Cell, Marginal Zone
57
Myelodysplastic Syndromes
52
Waldenstrom Macroglobulinemia
43
Lymphoma, T-Cell
42
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
38
Lymphoma, T-Cell, Peripheral
36
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Biphenotypic, Acute
28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
27
Leukemia, B-Cell
27
Mycosis Fungoides
25
Lymphoma, Large-Cell, Anaplastic
25
Sarcoma
24
Lymphoproliferative Disorders
20
Interventions
CLR1404
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Lymphoid
×
90 days
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled